Incyte | INCY - Eps Gewinn Pro Aktie

Aktienkurs
92.95
Täglich Wechseln
0.71 0.77%
Monatlich
-8.26%
Jährlich
53.43%
Q1 Prognose
89.75

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 1.42 1.16 May/05 2026
FY2025Q4 Dec/2025 1.80 1.93 1.43 Feb/10 2026
FY2025Q3 Sep/2025 2.26 1.58 1.07 Oct/28 2025
FY2025Q2 Jun/2025 1.57 1.40 -1.82 Jul/29 2025
FY2025Q1 Mar/2025 1.16 1.01 0.64 Apr/29 2025




Eps Veränderung Datum
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Agenus USD -0.3 0.84 2025-12
Agios Pharmaceuticals USD -1.86 0.08 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amgen USD 5.29 0.35 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Exelixis USD 0.97 0.19 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Incyte USD 1.8 0.46 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
MacroGenics USD -0.22 0.49 2025-12
Merck USD 2.04 0.54 2025-12
Moderna USD -2.11 1.6 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.5 2025-12
Novartis USD 1.54 0.48 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12